Stenotrophomonas maltophilia contamination of nebulizers used to deliver aerosolized therapy to inpatients with cystic fibrosis

Journal of Hospital Infection

Volumn 55, Issue 3, 2003, Pages 180-183

  Denton, Miles ^a   Rajgopal, A ^a   Mooney, L ^b   Qureshi, A ^b   Kerr, K G ^a,b   Keer, V ^a   Pollard, K ^c   Peckham, D G ^c   Conway, S P ^c  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c SEACROFT HOSPITAL   (United Kingdom)

Author keywords

Contamination; Cystic fibrosis; Nebulizers; Stenotrophomonas maltophilia

Indexed keywords

DRINKING WATER;

AEROSOL; ANALYTIC METHOD; ARTICLE; BACTERIAL STRAIN; BACTERIUM CONTAMINATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLEANING; CONTROLLED STUDY; CYSTIC FIBROSIS; FREQUENCY ANALYSIS; GENOTYPE; HOSPITAL EQUIPMENT; HOSPITAL PATIENT; HUMAN; INFECTION CONTROL; MEDICAL NEBULIZER; NONHUMAN; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; SAMPLING; STENOTROPHOMONAS MALTOPHILIA; WARD;

ADOLESCENT; ADULT; AEROSOLS; CYSTIC FIBROSIS; ELECTROPHORESIS, GEL, PULSED-FIELD; EQUIPMENT CONTAMINATION; HUMANS; NEBULIZERS AND VAPORIZERS; STENOTROPHOMONAS MALTOPHILIA; WATER MICROBIOLOGY;

EID: 0346092479     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0195-6701(03)00299-8     Document Type: Article

References (10)

1. Burns J.L. Emerson J. Stapp J.R. et al. Microbiology of sputum from patients at cystic fibrosis centers in the United States Clin Infect Dis 27 1998 158-163
2. Denton M. Stenotrophomonas maltophilia: an emerging problem in cystic fibrosis patients Rev Med Microbiol 8 1997 15-19
3. Denton M. Todd N.J. Kerr K.G. Hawkey P.M. Littlewood J.M. Molecular epidemiology of Stenotrophomonas maltophilia isolated from clinical specimens from patients with cystic fibrosis and associated environmental samples J Clin Microbiol 36 1998 1953-1958
4. Denton M. Todd N.J. Littlewood J.M. Role of anti-pseudomonal antibiotics in the emergence of Stenotrophomonas maltophilia in cystic fibrosis patients Eur J Clin Microbiol Infect Dis 15 1996 402-405
5. Denton M. Kerr K.G. Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia Clin Microbiol Rev 11 1998 57-80
6. Mooney L. Kerr K.G. Denton M. Survival of Stenotrophomonas maltophilia following exposure to concentrations of tobramycin used in aerosolized therapy for cystic fibrosis patients Int J Antimicrob Agents 17 2001 63-66
7. Hutchinson G.R. Parker S. Pryor J.A. et al. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant Gram-negative bacteria in patients with cystic fibrosis J Clin Microbiol 34 1996 584-587
8. Ramsey B.W. Pepe M.S. Quan J.M. et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis New Engl J Med 340 1999 23-33
9. Denton M. Hall M.J. Todd N.J. Kerr K.G. Littlewood J.M. Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium Clin Microbiol Infect 6 2000 397-398
10. Graff G.R. Burns J.L. Factors affecting the incidence of Stenotrophomonas maltophilia isolation in cystic fibrosis Chest 121 2002 1754-1760